RHD and rheumatic heart disease: The aim of this study was to estimate the incidence of RhD immunisation after implementation of first trimester non-invasive fetal RHD screening using cell-free fetal DNA in maternal plasma to selectively provide routine antenatal anti-D prophylaxis (RAADP) to RhD negative women carrying an RHD positive fetus.